Menu

Blog

Archive for the ‘biotech/medical’ category: Page 2295

May 26, 2018

PRESS RELEASE: Tactical Robotics’ Cormorant Achieves IDF Mission Demo Milestone

Posted by in categories: biotech/medical, robotics/AI

On May 7th, Tactical Robotics (a subsidiary of Urban Aeronautics Ltd), based in Yavne. Israel, successfully performed a first “mission representative” demonstration for its lead customer, the Israel Defence Forces. This milestone was announced for the first time today at the Israel Combat Rescue and Emergency Medicine conference where the company also presented Cormorant’s capability to be the first UAS system fielded for unmanned casualty evacuation missions.

Read more

May 26, 2018

New Harvard Startup Wants to Reverse Aging in Dogs and then Humans

Posted by in categories: biotech/medical, life extension

Professor George Church of Harvard Medical School has co-founded a new startup company, Rejuvenate Bio, which has plans to reverse aging in dogs as a way to market anti-aging therapies for our furry friends before bringing them to us.

Dogs first, humans next

The company has already carried some initial tests on beagles and plans to reverse aging by using gene therapy to add new instructions to their DNA. If it works, the goal is ultimately to try the same approach in people, and George Church may be one the first human volunteers.

Continue reading “New Harvard Startup Wants to Reverse Aging in Dogs and then Humans” »

May 26, 2018

A sensor could monitor gut health via engineered bacteria

Posted by in categories: bioengineering, biotech/medical, health

Esearchers have devised a new way to get a sneak peek into what’s going on deep in your digestive system, creating a swallowable sensor that, with the help of engineered bacteria and a tiny electrical circuit, can detect the presence of molecules that might be signs of disease and then beam the results to a smartphone app.

The device, which scientists validated in pigs, remains a prototype and needs to be refined before it could be used in people. But the researchers, who reported their work Thursday in the journal Science, combined innovations in synthetic biology and microelectronics to create a modular platform that could be adapted to identify a wide range of molecules.

Read more

May 26, 2018

This 3D Printer Can Help Grow Organs With Scaffolding Made Out of Sugar

Posted by in categories: 3D printing, biotech/medical

Sugar, that amazingly sweet treat some of us just can’t get enough of, has long been the fascination of children (and those with a child-like sweet tooth).

Its ability to be melted down into a glass-like substance enables confectionery artists to create tasty displays worthy of museums, or being served as a 3D printed dessert.

In fact, the same properties which make sugar so wonderful for cooking and designing also make it great for science.

Continue reading “This 3D Printer Can Help Grow Organs With Scaffolding Made Out of Sugar” »

May 25, 2018

After you die, some things in your body keep on ticking, this video reveals

Posted by in category: biotech/medical

Genes active after death may be important for transplant success and calculating time of death.

Read more

May 25, 2018

Nanoparticles carry drug duo into the brain to fight cancer

Posted by in categories: biotech/medical, nanotechnology, neuroscience

Glioblastoma is one of the most deadly forms of cancer. Affecting the brain, those unlucky enough to receive a diagnosis don’t have many treatment options – and usually a median life expectancy of just over a year. Now, researchers at MIT have developed nanoparticles that could provide hope, crossing the blood-brain barrier and delivering two types of drugs to fight tumors.

The MIT nanoparticles are liposomes, fatty droplets that can carry one drug on the inside and another in the outer layer. On the inside, the particles were loaded with a common chemotherapy drug called temozolomide, while the outer shell contained a more experimental substance known as JQ-1.

Read more

May 24, 2018

Measles makes alarming return to Europe and the Americas

Posted by in categories: biotech/medical, economics, health, neuroscience

Why it matters: Measles is a killer disease. It’s estimated that more than 2 million children a year died from measles in the 1980s, but due to global vaccine programs (including Gavi, the Vaccine Alliance launched in 2000), that number has been brought under 70,000 cases. The return of measles to Europe and the Americas could suggest that some of our vaccine successes could be reversing or unraveling. In the case of Venezuela, measles outbreaks are mostly due to the effect of broad economic problems on its health care system, but for Europe and the U.S. measles outbreaks show the effects of powerful and well-organized anti-vaccine movements.

What’s next: Vaccines do not cause autism, but more advocacy is needed to counteract the false claims of anti-vaccine groups. In April 2018, the European Commission proposed activities to strengthen the EU’s capacity to vaccinate its population and address what some call “vaccine hesitancy.” In the U.S., however, there are still 18 states that allow non-medical vaccine exemptions linked to personal or philosophical beliefs.

Peter Hotez is a professor and dean of the National School of Tropical Medicine at Baylor College of Medicine, where he is also director of the Texas Children’s Hospital Center for Vaccine Development, and the author of “Vaccines Did Not Cause Rachel’s Autism.”

Continue reading “Measles makes alarming return to Europe and the Americas” »

May 24, 2018

Swallowable ‘bacteria on a chip’ could help diagnose colon cancer, bowel disorders and gut ulcers

Posted by in categories: biotech/medical, computing, genetics, health

Unlike other ingestible chips, this new version by MIT contains millions of genetically engineered living cells to act as sensors, designed to light up when they detect bleeding.

It’s the latest advance in a growing field of sensors that can be swallowed or worn to monitor our health.

Pills equipped with cameras, thermometers and acidity gauges already look for disease and track digestion.

Continue reading “Swallowable ‘bacteria on a chip’ could help diagnose colon cancer, bowel disorders and gut ulcers” »

May 24, 2018

NASA is bringing cryosleep chambers out of fiction and into science

Posted by in categories: biotech/medical, space travel

You probably thought it was infinitely cool when Ripley and the crew of the Nostromo first emerged from their cryosleep chambers in Alien, but now that slice of sci-fi could become a reality in our lifetime.

NASA and SpaceWorks Enterprises are currently developing a stasis chamber (as opposed to individual pods like those in the movie) that could induce an extended state of torpor, or metabolic inactivity medically brought on by lowering body temperature to the point of mild hypothermia, that could allow astronauts to snooze for at least two weeks on end during longer missions. Also unlike Alien, in which everyone is temporarily in freeze-frame until the ship arrives at its destination, the crew would rotate cryosleep shifts so there is always someone conscious in case something goes awry where no one can here you scream.

SpaceWorks’ objective is to “place crew and passengers in a prolonged hypothermic state during space-mission transit phases (outbound and Earth-return) to significantly reduce the system mass, power, habitable volume, and medical challenges associated with long-duration space exploration,” as explained on their website.

Continue reading “NASA is bringing cryosleep chambers out of fiction and into science” »

May 24, 2018

Vascular risk appears to accelerate cognitive decline in old age

Posted by in categories: biotech/medical, life extension, neuroscience

Vascular risk and accumulation of beta-amyloids seem to accelerate the rate of cognitive decline in elderly adults.


Vascular risk appears to be a strong predictor of dementia, especially in older individuals with high levels of brain beta-amyloids, and the interaction between these two risk factors might lead to a higher rate of cognitive decline, according to a recent study at the Massachusetts General Hospital.

Alzheimer’s disease (AD) is an age-related neurological disorder whose most feared outcome is dementia, along with other symptoms, such as behavioral issues, loss of motivation, and even the inability to take care of oneself. Patients suffering from AD exhibit an accumulation of plaques in their brains; these plaques, resulting from the build-up of amyloid-beta protein, have long been thought to be the cause of the disease, though other hypotheses have been put forward as well.

Continue reading “Vascular risk appears to accelerate cognitive decline in old age” »